[
  {
    "ts": "2025-11-08T02:31:00+00:00",
    "headline": "Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer",
    "summary": "Metsera, Inc. (NASDAQ: MTSR) today announced that it has entered into an amended merger agreement with Pfizer, pursuant to which Pfizer will acquire Metsera for up to $86.25 per share, consisting of $65.60 per share in cash and a contingent value right (CVR) entitling holders to additional payments of up to $20.65 per share in cash.",
    "url": "https://finance.yahoo.com/news/pfizer-metsera-enter-merger-agreement-023100002.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "28cc0f00-9e6d-3c8e-9327-91db16df85f0",
      "content": {
        "id": "28cc0f00-9e6d-3c8e-9327-91db16df85f0",
        "contentType": "STORY",
        "title": "Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer",
        "description": "",
        "summary": "Metsera, Inc. (NASDAQ: MTSR) today announced that it has entered into an amended merger agreement with Pfizer, pursuant to which Pfizer will acquire Metsera for up to $86.25 per share, consisting of $65.60 per share in cash and a contingent value right (CVR) entitling holders to additional payments of up to $20.65 per share in cash.",
        "pubDate": "2025-11-08T02:31:00Z",
        "displayTime": "2025-11-08T02:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/eb406e6c71b993a03bb9115a8790db25",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h6khLfW7xyx4j3pmDWGaBQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/eb406e6c71b993a03bb9115a8790db25.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IJ6HuEqvDy1cyfEeho5IfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/eb406e6c71b993a03bb9115a8790db25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-metsera-enter-merger-agreement-023100002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-metsera-enter-merger-agreement-023100002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-08T03:50:00+00:00",
    "headline": "Pfizer and Metsera Reach Deal Expected to Top $10 Billion",
    "summary": "Pfizer  has agreed to buy the weight-loss drug startup  Metsera  in a deal that could be worth more than $10 billion, besting  Novo Nordisk  following a heated bidding war.  Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront and a contingent value right worth up to $20.65 a share, Metsera said Friday.  In September, Pfizer had agreed to buy Metsera for up to $7.3 billion.",
    "url": "https://www.wsj.com/health/pharma/pfizer-and-metsera-reach-deal-worth-up-to-10-billion-be5def52?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "fef399b8-e95d-3d7b-a294-f60dd4869bb5",
      "content": {
        "id": "fef399b8-e95d-3d7b-a294-f60dd4869bb5",
        "contentType": "STORY",
        "title": "Pfizer and Metsera Reach Deal Expected to Top $10 Billion",
        "description": "",
        "summary": "Pfizer  has agreed to buy the weight-loss drug startup  Metsera  in a deal that could be worth more than $10 billion, besting  Novo Nordisk  following a heated bidding war.  Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront and a contingent value right worth up to $20.65 a share, Metsera said Friday.  In September, Pfizer had agreed to buy Metsera for up to $7.3 billion.",
        "pubDate": "2025-11-08T03:50:00Z",
        "displayTime": "2025-11-08T03:50:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fef399b8-e95d-3d7b-a294-f60dd4869bb5/pfizer-and-metsera-reach-deal.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/3b6774ea810b8f54759159222b795648",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yHjLxewpFGrzQE7iCtUZFQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3b6774ea810b8f54759159222b795648.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bJVENmQP35_X8rYjPcVNrg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/3b6774ea810b8f54759159222b795648.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/pfizer-and-metsera-reach-deal-worth-up-to-10-billion-be5def52?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]